Impact of COVID-19 on metabolic parameters in patients with type 2 diabetes mellitus
Open Access
- 3 February 2025
- journal article
- research article
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 25 (1) , 1-7
Abstract
The Coronavirus Disease 2019 (COVID-19) pandemic has disproportionately affected individuals with Type 2 Diabetes Mellitus (T2DM), making them more susceptible to viral infections. Additionally, COVID-19 and the associated lockdown restrictions have influenced metabolic regulatory mechanisms in this population. This study aims to evaluate the impact of COVID-19 infection and lockdown measures on physiological parameters in individuals with T2DM. This retrospective cohort study included 118 individuals with a prior diagnosis of T2DM. Medical records were reviewed for laboratory tests conducted within three months before the onset of the COVID-19 pandemic in Iran. Fifty-nine patients with confirmed COVID-19 infection during the first three months of the pandemic underwent follow-up laboratory tests six months post-diagnosis. An age- and gender-matched group of 59 noninfected individuals underwent follow-up tests six months after the pandemic’s onset. Clinical and laboratory parameters were analyzed and compared within each group. In the COVID-19 positive group, significant reductions were observed in triglycerides (TG) (P = 0.001), total cholesterol (TC) (P = 0.028), body mass index (BMI) (P = 0.034), atherogenic index of plasma (AIP) (P = 0.027), triglyceride-glucose (TyG) index (P = 0.001), and triglyceride-glucose-BMI (TyG-BMI) index (P < 0.001) during the six months following infection compared to pre-pandemic levels. Other variables remained unchanged. In the COVID-19 negative group, significant reductions were noted in TC (P = 0.001) and low-density lipoprotein cholesterol (LDL-C) (P = 0.01). T2DM patients with mild to moderate COVID-19 infection exhibited improvements in TC, TG, BMI, and insulin-related indices. Lockdown restrictions were associated with decreased TC and LDL-C levels in T2DM patients without a history of COVID-19 infection.Keywords
All Related Versions
This publication has 54 references indexed in Scilit:
- Malnutrition in COVID-19 survivors: prevalence and risk factorsAging Clinical and Experimental Research, 2023
- Connecting the dots between inflammatory cascades of obesity and COVID-19 in light of mortal consequences—a reviewEnvironmental Science and Pollution Research, 2022
- Impact of diabetes on COVID‐19 mortality and hospital outcomes from a global perspective: An umbrella systematic review and meta‐analysisEndocrinology, Diabetes & Metabolism, 2022
- The impact of COVID-19 pandemic on glycemic control in patients with diabetes mellitus in Turkey: a multi-center study from KocaeliJournal of Diabetes & Metabolic Disorders, 2021
- SARS-CoV-2 infection induces beta cell transdifferentiationCell Metabolism, 2021
- COVID-19 is associated with clinically significant weight loss and risk of malnutrition, independent of hospitalisation: A post-hoc analysis of a prospective cohort studyClinical Nutrition, 2021
- A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection?Computers in Biology and Medicine, 2021
- Improved glycemic control amongst people with long-standing diabetes during COVID-19 lockdown: a prospective, observational, nested cohort studyInternational Journal of Diabetes in Developing Countries, 2020
- Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent AxisCell Metabolism, 2020
- Dietary advice for reducing cardiovascular risk2013